Description:

CALGB 90601: On-Study Form NCT00942331 Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=653FC86F-74B9-C88B-E040-BB89AD432982

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=653FC86F-74B9-C88B-E040-BB89AD432982

Keywords:
Versions (5) ▾
  1. 8/26/12
  2. 8/11/14
  3. 1/9/15
  4. 6/16/15
  5. 7/30/15
Uploaded on:

July 30, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

On-Study Advanced Urinary Tract Cancer CALGB 90601 NCT00942331

All Patients

  1. StudyEvent: CALGB 90601: On-Study Form
    1. All Patients
Header module
Initial Diagnosis
Bladder Malignant Neoplasm
Laboratory Values
10^3/mcL
1000/uL
mg/dL
mg/dl
U/L
U/L
U/L
U/L
ml/min
Urinalysis
g/24 hours
Prior Treatment - Systemic Regimens
Ccrr Module For Calgb: 90202 On-study